Elevated Eosinophils
Peripheral eosinophilia reflects activation of eosinophil-driven immune pathways, most commonly from allergic disease, medication hypersensitivity, or parasitic infection. [1][2][3] Marking eosinophilia can also indicate immune dysregulation, autoimmune disease, malignancy, or primary (clonal) hematologic disorders. [2][3]
Elevated Monocytes
Monocytosis reflects activation of the innate immune system, most commonly from infection or inflammatory or autoimmune disease. [4][5] Monocytosis can also be associated with hematologic malignancy and other marrow disorders. [4]
Clinical Significance Based on Magnitude
Eosinophilia severity correlates with risk of tissue involvement in selected syndromes. [3] Very severe eosinophilia (for example, eosinophil counts >100,000/µL) is associated with complications such as tissue ischemia when eosinophils aggregate in small vessels, usually in eosinophilic leukemia or related processes. [3] Hypereosinophilic syndrome is defined by sustained eosinophilia with organ-system manifestations or tissue eosinophilia and is commonly defined using an absolute eosinophil count >1,500 cells/µL. [6][7]
Differential Diagnosis Framework for Eosinophilia
Common categories include the following: [1][2][3]
- Allergic disorders and asthma or other hypersensitivity states. [1][2]
- Drug reactions, including severe cutaneous adverse reactions. [1][7]
- Parasitic infections and certain fungal infections. [1][3][7]
- Autoimmune or inflammatory disorders and vasculitis-related syndromes. [1][2][3]
- Malignancy or primary clonal hematologic eosinophilic disorders. [2][3][7]
Differential Diagnosis Framework for Monocytosis
Common categories include the following: [4][5]
- Acute or chronic infection. [4][5]
- Autoimmune disease and inflammatory disorders. [4][5]
- Hematologic malignancy or marrow disorders. [4]
Diagnostic Evaluation Priorities
Evaluation of both eosinophilia and monocytosis prioritizes searching for a reactive cause such as infection, allergy/drug exposure, autoimmune disease, or malignancy. [2][3][4] When eosinophilia is present, defining the absolute eosinophil count and assessing for symptoms suggesting organ involvement supports differentiation between uncomplicated reactive eosinophilia and hypereosinophilic processes. [3][7] When monocytosis persists, assessment for chronic inflammatory/infectious etiologies and marrow disorders supports risk stratification for hematologic disease. [4]
Common Pitfalls to Avoid
A common pitfall is attributing eosinophilia solely to allergy or “parasites” without confirming an absolute eosinophil count and the presence or absence of medication or exposure triggers and organ symptoms. [2][3][7] A common pitfall is dismissing monocytosis as nonspecific inflammation without considering persistent elevation and hematologic malignancy in the differential. [4]
Treatment Targets and Goals
Treatment targets the underlying cause of leukocyte elevation. [2][3][4] In eosinophilic disorders, the clinical goal is prevention of organ damage when eosinophilia is associated with hypereosinophilic syndromes or eosinophilic leukemia. [3][7] In monocytosis, the clinical goal is treatment of the responsible infection, inflammatory condition, or hematologic disorder. [4]